Treatment of human African trypanosomiasis—present situation and needs for research and development
- 1 July 2002
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 2 (7) , 437-440
- https://doi.org/10.1016/s1473-3099(02)00321-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Clinical and epidemiological aspects of Chagas diseaseThe Lancet Infectious Diseases, 2001
- The situation of sleeping sickness in Angola: a calamity.Tropical Medicine & International Health, 2001
- Melarsoprol refractory T. b. gambiense from Omugo, north‐western UgandaTropical Medicine & International Health, 2001
- Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trialThe Lancet, 2000
- Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda.Transactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Relapses following treatment of early-stage Trypanosoma brucei gambiense sleeping sickness with a combination of pentamidine and suraminTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996
- The Treatment of Human African TrypanosomiasisAdvances in Parasitology, 1994
- Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sicknessPublished by Elsevier ,1992
- High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central ZaireTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Difiuoromethylornithine in the treatment of African trypanosomiasisParasitology Today, 1986